AbCellera
ust help everyone share in the success partner clinical phase phase pee tell building a diversified portfolio of milestones royalties primary value driver discovery research fees milestones near term revenue from research rill multimillion dollar potential clinical and commercial milestone payments majority of risk adjusted value from royalty on commercial therapeutic | AbCellera
Company
Deck Type
IPO
Sector
Industry
Deck date
December 2020
Slide
13 of 38
Related slides by other companies
BenevolentAI
Investor Presentation
October 2022
therapy area and business model rationale competitive commercial scientific commercial clinical development data core therapeutic areas clinical development development out license at phase i or phase scientific strategy out license prior to phase i non core therapeutic areas collaborations non commercial collaborations | BenevolentAI
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights